Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

IPO Failures Can Set Up Biotech Successes

Oct 01 2006

• By Roger Longman

Related Content

Speedel Group: Strings Attached? No Problem

Feb 01 2004

Theravance: Having Cake and Eating It

Mar 01 2005

Infinity Reverse Merges Into Discovery Partners

May 01 2006

The Price is Wrong: Finding Alternatives to Traditional IPOs

Jun 01 2006

Related Companies

Gilead Sciences, Inc.

Biogen, Inc.

GlycoFi Inc.

Pfizer Inc.

Gyre Therapeutics, Inc.

AstraZeneca PLC

Acorda Therapeutics, Inc.

Novartis AG

Novartis AG

Infinity Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc.

Life Technologies Corporation

Anesiva, Inc.

PharmAthene, Inc.

SIGA Technologies, Inc

Ligand Pharmaceuticals, Inc.

Gilead Sciences, Inc.

Bausch Health Companies Inc.

Johnson & Johnson

Cerexa Inc.

Aderis Pharmaceuticals, Inc.

Alseres Pharmaceuticals Inc.

Astellas Pharma, Inc.

Cardiome Pharma Corp.

King Pharmaceuticals, Inc.

Reliant Pharmaceuticals

Intarcia Therapeutics, Inc.

Tolerx, Inc.

Amicus Therapeutics, Inc.

Pfizer Inc.

Innoviva, Inc.

Additional Topics

Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window